Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
MedPage Today on MSN
FDA approves at-home device for treatment-resistant depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
When treatments such as medication and therapy aren’t able to relieve the symptoms of depression or another mental health condition, there are other options available. A psychiatrist might suggest ...
A clinic in Bellevue talks about transcranial magnetic stimulation. The new technology is becoming more widely available to ...
Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base ...
New research supports the therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) for Alzheimer’s disease (AD). In a 52-week phase 2 trial, personalized rTMS applied over the ...
16d
Brain Treatment USA Releases Expanded Case Narrative and Research Overview on rTMS in Autism Studies
A family case narrative and recent research highlight how EEG-guided rTMS is being studied in autism research. WIMBERLEY, TX, UNITED STATES, December 30, 2025 /EINPresswire.com/ — Brain Treatment USA ...
Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that delivers magnetic pulses to the brain to change neural activity. It is used to treat mental health disorders, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback